Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle T Long

Showing results (71-80 of 98) with videos related to

Pageof 10
Sort By:
The New England Journal of Medicine|April 30, 2025
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated SteatohepatitisArun J Sanyal, Philip N Newsome, Iris Kliers, et al.
Hepatology (Baltimore, Md.)|January 18, 2023
The association between hepatic steatosis and incident cardiovascular disease, cancer, and all-cause mortality in a US multicohort studyHeidi S Ahmed, Na Wang, J Jeffrey Carr, et al.
The Journal of Clinical Endocrinology and Metabolism|July 2, 2022
The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/ObesityLaura E Dichtel, Kathleen E Corey, Melanie S Haines, et al.
The American Journal of Medicine|May 17, 2022
Alcohol Consumption and Cardiovascular HealthChayakrit Krittanawong, Ameesh Isath, Robert S Rosenson, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2023
Growth Hormone Administration Improves Nonalcoholic Fatty Liver Disease in Overweight/Obesity: A Randomized TrialLaura E Dichtel, Kathleen E Corey, Melanie S Haines, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2015
Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart studyMichelle T Long, Na Wang, Martin G Larson, et al.
Journal of the American Heart Association|July 5, 2021
Cardiovascular Biomarkers of Obesity and Overlap With Cardiometabolic DysfunctionEmily S Lau, Samantha M Paniagua, Shahrooz Zarbafian, et al.
Plos One|March 7, 2019
Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitalsV V Pavan Kedar Mukthinuthalapati, Samuel Akinyeye, Zachary P Fricker, et al.
Journal of the American Heart Association|May 4, 2017
Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart StudyMichelle T Long, Xiaoyan Yin, Martin G Larson, et al.
American Journal of Hypertension|April 5, 2024
Trends in the Prevalence of Multiple Chronic Conditions Among US Adults With Hypertension From 1999-2000 Through 2017-2020Chibuike J Alanaeme, Lama Ghazi, Oluwasegun P Akinyelure, et al.
Pageof 10

Showing results (71-80 of 98) with videos related to

Sort By:
Pageof 10
The New England Journal of Medicine|April 30, 2025
Phase 3 Trial of Semaglutide in Metabolic Dysfunction-Associated SteatohepatitisArun J Sanyal, Philip N Newsome, Iris Kliers, et al.
Hepatology (Baltimore, Md.)|January 18, 2023
The association between hepatic steatosis and incident cardiovascular disease, cancer, and all-cause mortality in a US multicohort studyHeidi S Ahmed, Na Wang, J Jeffrey Carr, et al.
The Journal of Clinical Endocrinology and Metabolism|July 2, 2022
The GH/IGF-1 Axis Is Associated With Intrahepatic Lipid Content and Hepatocellular Damage in Overweight/ObesityLaura E Dichtel, Kathleen E Corey, Melanie S Haines, et al.
The American Journal of Medicine|May 17, 2022
Alcohol Consumption and Cardiovascular HealthChayakrit Krittanawong, Ameesh Isath, Robert S Rosenson, et al.
The Journal of Clinical Endocrinology and Metabolism|June 28, 2023
Growth Hormone Administration Improves Nonalcoholic Fatty Liver Disease in Overweight/Obesity: A Randomized TrialLaura E Dichtel, Kathleen E Corey, Melanie S Haines, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 7, 2015
Nonalcoholic fatty liver disease and vascular function: cross-sectional analysis in the Framingham heart studyMichelle T Long, Na Wang, Martin G Larson, et al.
Journal of the American Heart Association|July 5, 2021
Cardiovascular Biomarkers of Obesity and Overlap With Cardiometabolic DysfunctionEmily S Lau, Samantha M Paniagua, Shahrooz Zarbafian, et al.
Plos One|March 7, 2019
Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitalsV V Pavan Kedar Mukthinuthalapati, Samuel Akinyeye, Zachary P Fricker, et al.
Journal of the American Heart Association|May 4, 2017
Relations of Liver Fat With Prevalent and Incident Atrial Fibrillation in the Framingham Heart StudyMichelle T Long, Xiaoyan Yin, Martin G Larson, et al.
American Journal of Hypertension|April 5, 2024
Trends in the Prevalence of Multiple Chronic Conditions Among US Adults With Hypertension From 1999-2000 Through 2017-2020Chibuike J Alanaeme, Lama Ghazi, Oluwasegun P Akinyelure, et al.
Pageof 10